Skip to content
Search

Latest Stories

Submit Guest Post

ICMR defends India's COVID-19 testing strategy

THE Indian Council of Medical Research(ICMR) has clarified that the testing ratio in India is not low.

It added that there has been no COVID-19 infections in 325 of the 736 districts.


India has 13,387 coronavirus positive cases in the country with 437 deaths.

Recently, congress leader Rahul Gandhi said that India was not conducting enough coronavirus tests.

India also received the much-awaited 500,000 rapid COVID-19 testing kits from China on Thursday (16), the government said.

"In countries like Japan, one out of 11.7 tests turns out to be positive, which is among the highest in the world. Italy tests 6.7 persons for one positive test while the US tests 5.3 persons and the United Kingdom 3.4," said Dr Raman R Gangakhedkar, head of epidemiology and communicable diseases at the ICMR.

"In India, we are conducting 24 tests out of which one comes out to be positive. Also, we have huge population and not all people belong to vulnerable groups. Hence, can't say our testing ratio is low".

Rahul Gandhi said that aggressive testing is the main weapon to defeat the coronavirus and it should be used strategically.

Gangakhedkar said the testing kits from China will be used for surveillance and to monitor whether coronavirus hotspots in the country are increasing or decreasing.

Coronavirus cases crossed 1,000 in Madhya Pradesh(1,090) and Rajasthan(1,104)  taking to five the states which have surpassed this mark.

Maharashtra topped the tally at 3,081 with Mumbai (2,043) being the worst hit followed by Delhi(1,578) and Tamil Nadu(1,267). The cases in Mumbai have doubled in six days.

The Centre has declared 170 hotspots--123 hotspot districts with large outbreaks and 47 hotspot districts with cluster-- in 25 states and Union territories.

Besides, it has identified 207 non-hotspot districts with clusters in 27 states which can be potential hot spots if there is no containment strategies.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

PCOS

PCOS must be recognised as a chronic condition

iStock

Why PCOS poses a greater long-term health risk for South Asian women

Dr Kalpana Purshottamdas Lakhani

PCOS is often dismissed as a reproductive issue, but for south Asian women the consequences reach far beyond the ovary — affecting metabolic health, fertility, and lifelong wellbeing.

Polycystic ovary syndrome (PCOS) is one of the most common hormonal conditions in women, affecting an estimated 8–13% worldwide. But for south Asian women, the impact is even greater — and far less recognised. Research shows that south Asian women have higher insulin resistance, develop type 2 diabetes five to ten years earlier than white European women, and experience more severe metabolic features when they have PCOS. They also face higher rates of gestational diabetes and earlier cardiovascular risk. These differences make the long-term consequences of PCOS particularly significant in this community.

Keep ReadingShow less